Stuart John Ashman, Director at SkinBioTherapeutics, holds 281.25K shares in SkinBioTherapeutics (Ticker: GB:SBTX). Most recently, Stuart John Ashman Bought 156,250p shares of SkinBioTherapeutics on Dec 16, 2022 for an estimated value of 25.00K.
What is the percentage of profitable transactions made by Stuart John Ashman?
The percentage of profitable transactions made by Stuart John Ashman is 50%.
What is the average return per transaction made by Stuart John Ashman?
The average return per transaction made by Stuart John Ashman is 122.80%.
What stocks does Stuart John Ashman hold?
Stuart John Ashman holds: GB:SBTX stocks.
What was Stuart John Ashman’s latest transaction?
Stuart John Ashman latest transaction was an Informative Buy of 25.00K.
What was Stuart John Ashman's most profitable transaction?
Stuart John Ashman’s most profitable transaction was an Informative Buy of GB:SBTX stock on October 14, 2020. The return on the trade was 245.80%.
What is Stuart John Ashman's role in SkinBioTherapeutics?
Stuart John Ashman's role in SkinBioTherapeutics is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.